Numerous studies have reported that the dysregulation of the Wnt/β-catenin pathway contributes to the regulation of VEGF expression, tumor angiogenesis and that VEGF is a novel target of the Wnt pathway [5, 6]. The gene discussed is VEGFA; the disease is neoplasm.